Tolerance and efficacy of praziquantel in phase II A and II B therapeutic trials in Zambian patients
Davis, A.; Biles, J.E.; Ulrich, A.M.; Dixon, H.
Arzneimittel-Forschung 31(3a): 568-574
1981
ISSN/ISBN: 0004-4172 PMID: 7195247 Document Number: 175356
Schistosoma haematobium, patients, clinical trials testing efficacy and tolerance of praziquantel: Zambia
Document emailed within 1 workday
Related Documents
El-Sayad, M.H.; Lotfy, W.M.; el-Kholy, S.M.; Yehia, M.A.H. 2002: Efficacy of praziquantel against Giardia lamblia in rats: parasitological, pathological and therapeutic study Journal of the Egyptian Society of Parasitology 32(1): 201-218Wu, M.H.; Wei, C.C.; Xu, Z.Y.; Yuan, H.C.; Lian, W.N.; Yang, Q.J.; Chen, M.; Wang, C.Z.; Zhang, Z.J.; Liu, Z.D. 1991: Comparative efficacy of levo-praziquantel and praziquantel in treatment of schistosomiasis japonica at a single dose Chinese Medical Journal 104(9): 732-735
Xiao, S.H.; You, J.Q.; Guo, H.F. 1992: Plasma pharmacokinetics and therapeutic efficacy of praziquantel and 4-hydroxypraziquantel in Schistosoma japonicum-infected rabbits after oral, rectal, and intramuscular administration American Journal of Tropical Medicine and Hygiene 46(5): 582-588
Brinkman-Woltjer, L.F.; Vermorken, J.B.; van Groeningen, C.J.; Gall, H.E.; Pinedo, H.M. 1988: Phase i studies as non-therapeutic trials in oncology Nederlands Tijdschrift Voor Geneeskunde 132(51): 2321-2325
Pignon, J.P. 1992: Phase II therapeutic trials in Cancerology: what's new? For a better multicenter and multidisciplinary cooperation Gastroenterologie Clinique et Biologique 16(2): 131-133
Becouarn, Y.; Rougier, P. 1998: Clinical efficacy of oxaliplatin monotherapy: phase Ii trials in advanced colorectal cancer Seminars in Oncology 25(2 Suppl 5: 23-31
Horstmann, R.D.; Feldheim, W.; Feldmeier, H.; Dietrich, M. 1981: High efficacy of praziquantel in the treatment of 22 patients with Clonorchis/Opisthorchis infections Tropenmedizin und Parasitologie 32(3): 157-160
Feuerstein, J.; Revol, M.; Roger, J.; Sallou, C.; Truelle, J.L.; Vercelletto, P.; Weber, M. 1983: Monotherapy with sodium valproate in generalized primary epilepsy. 2d phase: Study of long-term efficacy and tolerance La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(16): 1263-1274
Alkabes, M.; Palmieri, G.; Bellasio, G.; Procaccia, S. 1978: Evaluation of the therapeutic efficacy and tolerance of diphenpyramide in a double-blind comparison with indomethacin in the treatment of osteoarthrosis La Clinica Terapeutica 86(2): 137-145
Lebwohl, M.G..; Sugarman, J.L..; Stein Gold, L.; Lin, T.; Israel, R. 2019: Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of two Phase IIi Randomized Controlled Trials Journal of Drugs in Dermatology: Jdd 18(10): 1012-1018
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Trimble, E.L.; Schoenfeldt, M. 2004: Clinical trials referral source. Current randomized phase IIi trials in gynecologic cancer Oncology 18(13): 1642; 1645-1646
Hou, M-Mo.; Liu, X.; Wheler, J.; Naing, A.; Hong, D.; Bodurka, D.; Schmeler, K.; Tsimberidou, A.; Janku, F.; Zinner, R.; Piha-Paul, S.; Hu, C-Yuan.; Lu, K.; Kurzrock, R.; Fu, S. 2014: Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program Anticancer Research 34(5): 2349-2355
Jaoko, W.G.; Ogutu, H.; Wakasiaka, S.; Malogo, R.; Ndambuki, R.; Nyange, J.; Omosa-Manyonyi, G.; Fast, P.; Schmidt, C.; Verlinde, C.; Smith, C.; Bhatt, K.M.; Ndinya-Achola, J.; Anzala, O. 2009: Pregnancy rates among female participants in phase i and phase IIA AIDS vaccine clinical trials in Kenya East African Medical Journal 86(9): 430-434
Lancaster Smith, M.J.; Miller, J.P.; Whorwell, P.J. 1989: Efficacy and tolerance of Algicon in patients with reflux oesophagitis British Journal of Clinical Practice. Suppl 66: 38-42; Discussion: 61-64
Jaillon, P.; Dupuis, B. 1989: Prerequisites for phase i and phase Ii clinical trials of drugs Archives des Maladies du Coeur et des Vaisseaux 82(10): 1773-1776
Waitzberg, D.L.; Pinto Júnior, P.E.; D'Albuquerque, L.A.; Ciosak, S.I.; Gomes, M.L.; Imakado, C.S.; Habr-Gama, A.; Gama-Rodrigues, J. 1985: Efficacy and tolerance of a new dietetic enteral formula in malnourished patients Amb: Revista da Associacao Medica Brasileira 31(11-12): 214-222
Pol, S. 2002: Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance Gastroenterologie Clinique et Biologique 26(Special Issue 2): B264-B273
Yagoda, A. 1977: Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer Cancer Research 37(8 Part 2): 2775-2780
Rubik, J.; Grenda, R.; Dzierzanowska, D. 1995: Evaluation of the efficacy, tolerance and safety of Biotrakson use in patients with kidney failure Pediatria Polska 70(12): 1043-1052